{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:01:19Z","timestamp":1790074879200,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital Health Network","award":["PURE ID 32345476"],"award-info":[{"award-number":["PURE ID 32345476"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Residents of residential aged care facilities (RACFs) have a high prevalence of use of potentially inappropriate medications (PIMs) and resultant medicines-related harm. This study investigated the effect of an on-site pharmacist model on PIMs use and other medication outcomes for residents in RACFs. A multi-facility, non-blind, cluster randomised controlled trial, with randomisation at the facility level, was conducted. Fifteen facilities enrolled and participated in the study, 7 facilities (560 residents) were allocated to the intervention arm and 8 facilities (737 residents) were allocated to the control arm. Each facility in the intervention arm employed an on-site pharmacist for 12\u00a0months to perform medication management activities as part of an interdisciplinary care team. The primary outcome was the proportion of residents taking at least one PIM according to the 2019 Beers\u00ae Criteria. Using generalised linear mixed-effects models, accounting for confounders and clustering, there was a significant reduction in the proportion of residents prescribed at least one PIM (odds ratio 0.50, 95% confidence interval, 0.335\u20130.750; p\u2009=\u20090.001) in the intervention arm. There were also significant decreases in the Anticholinergic Cognitive Burden scale and chlorpromazine equivalent daily dose of antipsychotics. The on-site pharmacist intervention significantly improved the appropriateness of medicines use in RACFs.<\/jats:p>","DOI":"10.1038\/s41598-023-42894-5","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:02:23Z","timestamp":1695621743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of on-site pharmacists in residential aged care facilities on the quality of medicines use: a cluster randomised controlled trial (PiRACF study)"],"prefix":"10.1038","volume":"13","author":[{"given":"Ibrahim","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Niyonsenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Koerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"42894_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2042098610381418","volume":"1","author":"NM Wilson","year":"2010","unstructured":"Wilson, N. M., March, L. M., Sambrook, P. N. & Hilmer, S. N. Medication safety in residential aged-care facilities: A perspective. Therap. Adv. Drug Saf. 1, 11\u201320 (2010).","journal-title":"Therap. Adv. Drug Saf."},{"key":"42894_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cger.2012.01.002","volume":"28","author":"BM Shah","year":"2012","unstructured":"Shah, B. M. & Hajjar, E. R. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin. Geriatr. Med. 28, 173\u2013186 (2012).","journal-title":"Clin. Geriatr. Med."},{"key":"42894_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar, E. R., Cafiero, A. C. & Hanlon, J. T. Polypharmacy in elderly patients. Am. J. Geriatr. Pharmacother. 5, 345\u2013351 (2007).","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"42894_CR4","unstructured":"Pharmaceutical society of Australia. PROGRAM RULES Home Medicines Review. https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2019\/01\/HMR-Program-Rules.pdf (2019)"},{"key":"42894_CR5","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.3390\/jcm11175189","volume":"11","author":"I Haider","year":"2022","unstructured":"Haider, I. et al. Quality use of medicines indicators and associated factors in residential aged care facilities: Baseline findings from the pharmacists in RACF study in Australia. J. Clin. Med. 11, 5189 (2022).","journal-title":"J. Clin. Med."},{"key":"42894_CR6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/1060028019853069","volume":"53","author":"XX Xing","year":"2019","unstructured":"Xing, X. X. et al. Associations between potentially inappropriate medications and adverse health outcomes in the elderly: A systematic review and meta-analysis. Ann. Pharmacother. 53, 1005\u20131019 (2019).","journal-title":"Ann. Pharmacother."},{"key":"42894_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40266-020-00770-1","volume":"37","author":"ER Weeda","year":"2020","unstructured":"Weeda, E. R., AlDoughaim, M. & Criddle, S. Association between potentially inappropriate medications and hospital encounters among older adults: A meta-analysis. Drugs Aging 37, 529\u2013537 (2020).","journal-title":"Drugs Aging"},{"key":"42894_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12877-018-0757-8","volume":"18","author":"SL Harrison","year":"2018","unstructured":"Harrison, S. L. et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 18, 66 (2018).","journal-title":"BMC Geriatr."},{"key":"42894_CR9","unstructured":"Royal Commission into Aged Care Quality and Safety. Final Report. Royal Commission into Aged Care Quality and Safety. https:\/\/agedcare.royalcommission.gov.au\/publications\/final-report (2021)."},{"key":"42894_CR10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2012.211266","volume":"309","author":"BA Briesacher","year":"2013","unstructured":"Briesacher, B. A., Tjia, J., Field, T., Peterson, D. & Gurwitz, J. H. Antipsychotic use among nursing home residents. J. Am. Med. Assoc. 309, 440 (2013).","journal-title":"J. Am. Med. Assoc."},{"key":"42894_CR11","first-page":"147130121879579","volume":"19","author":"K Westaway","year":"2018","unstructured":"Westaway, K. et al. The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review. Dementia 19, 147130121879579 (2018).","journal-title":"Dementia"},{"key":"42894_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury, J., Gee, P., Ling, T., Kitsos, A. & Peterson, G. More action needed: Psychotropic prescribing in Australian residential aged care. Aust. N. Z. J. Psychiatry 53, 136\u2013147 (2019).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"42894_CR13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/intqhc\/mzy098","volume":"30","author":"LG Pont","year":"2018","unstructured":"Pont, L. G., Raban, M. Z., Jorgensen, M. L., Georgiou, A. & Westbrook, J. I. Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: Variation in polypharmacy and antipsychotic use. Int. J. Qual. Health Care 30, 810\u2013816 (2018).","journal-title":"Int. J. Qual. Health Care"},{"key":"42894_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/WAD.0000000000000336","volume":"33","author":"EK Lind","year":"2019","unstructured":"Lind, E. K., Raban, Z. M., Georgiou, A. & Johanna, I. Duration of antipsychotic medication use by aged care facility residents with dementia. Alzheimer Dis. Assoc. Disord. 33, 331\u2013338 (2019).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"42894_CR15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/11588470-000000000-00000","volume":"34","author":"N Pratt","year":"2011","unstructured":"Pratt, N., Roughead, E. E., Ramsay, E., Salter, A. & Ryan, P. Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly. Drug Saf. 34, 567\u2013575 (2011).","journal-title":"Drug Saf."},{"key":"42894_CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pds.1942","volume":"19","author":"N Pratt","year":"2010","unstructured":"Pratt, N., Roughead, E. E., Ryan, P. & Salter, A. Antipsychotics and the risk of death in the elderly: An instrumental variable analysis using two preference based instruments. Pharmacoepidemiol. Drug Saf. 19, 699\u2013707 (2010).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"42894_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jalz.2012.02.005","volume":"9","author":"X Cai","year":"2013","unstructured":"Cai, X., Campbell, N., Khan, B., Chan, C. & Boustani, M. Long-term anticholinergic use and the aging brain. Alzheimer\u2019s Dementia 9, 377\u2013385 (2013).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"42894_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carri\u00e8re","year":"2009","unstructured":"Carri\u00e8re, I. et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population. Arch. Intern. Med. 169, 1317 (2009).","journal-title":"Arch. Intern. Med."},{"key":"42894_CR19","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/jgs.13054","volume":"62","author":"LM Kalisch Ellett","year":"2014","unstructured":"Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D. & Roughead, E. E. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J. Am. Geriatr. Soc. 62, 1916\u20131922 (2014).","journal-title":"J. Am. Geriatr. Soc."},{"key":"42894_CR20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13607863.2021.1922601","volume":"26","author":"DA Wiggin","year":"2021","unstructured":"Wiggin, D. A., Timmons, S., Rukundo, A. & Walsh, K. A. Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: An overview of reviews. Aging Ment. Health 26, 1087\u20131094 (2021).","journal-title":"Aging Ment. Health"},{"key":"42894_CR21","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.3390\/ijerph182312773","volume":"18","author":"I Haider","year":"2021","unstructured":"Haider, I. et al. How do pharmacists practice in aged care? A narrative review of models from Australia, England, and the United States of America. Int. J. Environ. Res. Public Health 18, 12773 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"42894_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jamda.2016.12.069","volume":"18","author":"AA Al-Jumaili","year":"2017","unstructured":"Al-Jumaili, A. A. & Doucette, W. R. Comprehensive literature review of factors influencing medication safety in nursing homes: Using a systems model. J. Am. Med. Dir. Assoc. 18, 470\u2013488 (2017).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"42894_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajag.12676","volume":"38","author":"EYH Chen","year":"2019","unstructured":"Chen, E. Y. H. et al. Process, impact and outcomes of medication review in Australian residential aged care facilities: A systematic review. Australas. J. Ageing 38, 9\u201325 (2019).","journal-title":"Australas. J. Ageing"},{"key":"42894_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/ijerph15030499","volume":"15","author":"N McDerby","year":"2018","unstructured":"McDerby, N., Naunton, M., Shield, A., Bail, K. & Kosari, S. Feasibility of integrating residential care pharmacists into aged care homes to improve quality use of medicines: Study protocol for a non-randomised controlled pilot trial. Int. J. Environ. Res. Public Health 15, 499 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"42894_CR25","unstructured":"Pharmaceutical society of Australia. Guidelines for pharmacists providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) services. https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2019\/01\/PSA-RMMR-and-QUM-Guidelines.pdf (2017)."},{"key":"42894_CR26","unstructured":"Department of Health and Aging. Guiding principles for medication management in residential aged care facilities. https:\/\/www.health.gov.au\/resources\/publications\/guiding-principles-for-medication-management-in-residential-aged-care-facilities?language=en (2022)."},{"key":"42894_CR27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2016.12.011","volume":"116","author":"JK Sluggett","year":"2017","unstructured":"Sluggett, J. K., Ilom\u00e4ki, J., Seaman, K. L., Corlis, M. & Bell, J. S. Medication management policy, practice and research in Australian residential aged care: Current and future directions. Pharmacol. Res. 116, 20\u201328 (2017).","journal-title":"Pharmacol. Res."},{"key":"42894_CR28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13063-021-05335-0","volume":"22","author":"S Kosari","year":"2021","unstructured":"Kosari, S. et al. Integrating pharmacists into aged care facilities to improve the quality use of medicine (PiRACF Study): protocol for a cluster randomised controlled trial. Trials 22, 66 (2021).","journal-title":"Trials"},{"key":"42894_CR29","doi-asserted-by":"crossref","first-page":"e5661","DOI":"10.1136\/bmj.e5661","volume":"345","author":"MK Campbell","year":"2012","unstructured":"Campbell, M. K., Piaggio, G., Elbourne, D. R. & Altman, D. G. Consort 2010 statement: Extension to cluster randomised trials. BMJ 345, e5661\u2013e5661 (2012).","journal-title":"BMJ"},{"key":"42894_CR30","first-page":"66","volume":"720","author":"N McDerby","year":"2020","unstructured":"McDerby, N. et al. Residential aged care pharmacist: An Australian pilot trial exploring the impact on quality use of medicines indicators. Medicines 720, 66 (2020).","journal-title":"Medicines"},{"key":"42894_CR31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jcpt.12822","volume":"44","author":"N McDerby","year":"2019","unstructured":"McDerby, N. et al. The effect of a residential care pharmacist on medication administration practices in aged care: A controlled trial. J. Clin. Pharm. Ther. 44, 595\u2013602 (2019).","journal-title":"J. Clin. Pharm. Ther."},{"key":"42894_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/ajag.12611","volume":"38","author":"NC McDerby","year":"2019","unstructured":"McDerby, N. C. et al. Pharmacist-led influenza vaccination services in residential aged care homes: A pilot study. Australas. J. Ageing 38, 132\u2013135 (2019).","journal-title":"Australas. J. Ageing"},{"key":"42894_CR33","first-page":"66","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society. American geriatrics society 2019 updated AGS beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 67, 66 (2019).","journal-title":"J. Am. Geriatr. Soc."},{"key":"42894_CR34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40266-017-0513-3","volume":"35","author":"SL Harrison","year":"2018","unstructured":"Harrison, S. L. et al. Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care. Drugs Aging 35, 83\u201391 (2018).","journal-title":"Drugs Aging"},{"key":"42894_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/nur.20232","volume":"31","author":"DM Fick","year":"2008","unstructured":"Fick, D. M., Mion, L. C., Beers, M. H. & Waller, L. J. Health outcomes associated with potentially inappropriate medication use in older adults. Res. Nurs. Health 31, 42\u201351 (2008).","journal-title":"Res. Nurs. Health"},{"key":"42894_CR36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajag.12312","volume":"35","author":"D N\u00ed Chr\u00f3in\u00edn","year":"2016","unstructured":"N\u00ed Chr\u00f3in\u00edn, D. et al. Potentially inappropriate medications (PIMs) in older hospital in-patients: Prevalence, contribution to hospital admission and documentation of rationale for continuation. Australas. J. Ageing 35, 262\u2013265 (2016).","journal-title":"Australas. J. Ageing"},{"key":"42894_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","volume":"64","author":"SW Woods","year":"2003","unstructured":"Woods, S. W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 64, 663\u2013667 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"42894_CR38","doi-asserted-by":"crossref","unstructured":"Hoffmann, F. Benefits and risks of benzodiazepines and Z-drugs: Comparison of perceptions of GPs and community pharmacists in Germany. German Med. Sci. GMS e-J. 11, Doc10 (2013).","DOI":"10.4414\/smw.2013.13745"},{"key":"42894_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani, M., Campbell, N., Munger, S., Maidment, I. & Fox, C. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 4, 311\u2013320 (2008).","journal-title":"Aging Health"},{"key":"42894_CR40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11096-021-01293-4","volume":"43","author":"C Stewart","year":"2021","unstructured":"Stewart, C. et al. Barriers and facilitators to reducing anticholinergic burden: A qualitative systematic review. Int. J. Clin. Pharm. 43, 1451\u20131460 (2021).","journal-title":"Int. J. Clin. Pharm."},{"key":"42894_CR41","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/sim.7336","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin, P. C. & Merlo, J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat. Med. 36, 3257\u20133277 (2017).","journal-title":"Stat. Med."},{"key":"42894_CR42","unstructured":"Australian Government: Department of Health and Aged Care. Education program to help improve dementia care. https:\/\/www.health.gov.au\/news\/announcements\/education-program-to-help-improve-dementia-care (2021)."},{"key":"42894_CR43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02982662","volume":"12","author":"S Vliek","year":"2008","unstructured":"Vliek, S. et al. Single versus multicomponent intervention in frail elderly: Simplicity or complexity as precondition for success?. J. Nutr. Health Aging 12, 319\u2013322 (2008).","journal-title":"J. Nutr. Health Aging"},{"key":"42894_CR44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ageing\/afm122","volume":"36","author":"AJ Campbell","year":"2007","unstructured":"Campbell, A. J. & Robertson, M. C. Rethinking individual and community fall prevention strategies: A meta-regression comparing single and multifactorial interventions. Age Ageing 36, 656\u2013662 (2007).","journal-title":"Age Ageing"},{"key":"42894_CR45","first-page":"66","volume":"87","author":"S Ali","year":"2021","unstructured":"Ali, S., Salahudeen, M. S., Bereznicki, L. R. E. & Curtain, C. M. Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review. Brit. J. Clin. Pharmacol. 87, 66 (2021).","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"42894_CR46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40545-023-00587-4","volume":"16","author":"I Haider","year":"2023","unstructured":"Haider, I. et al. The role of on-site pharmacist in residential aged care facilities: Findings from the PiRACF study. J. Pharm. Policy Pract. 16, 82 (2023).","journal-title":"J. Pharm. Policy Pract."},{"key":"42894_CR47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jppr.1041","volume":"44","author":"RA Elliott","year":"2014","unstructured":"Elliott, R. A. & Booth, C. J. Problems with medicine use in older Australians: A review of recent literature. J. Pharm. Pract. Res 44, 258\u2013271 (2014).","journal-title":"J. Pharm. Pract. Res"},{"key":"42894_CR48","first-page":"66","volume":"18","author":"K Thiruchelvam","year":"2022","unstructured":"Thiruchelvam, K., Byles, J., Hasan, S. S., Egan, N. & Kairuz, T. Impact of medication reviews on potentially inappropriate medications and associated costs among older women in aged care. Res. Soc. Adm. Pharm. 18, 66 (2022).","journal-title":"Res. Soc. Adm. Pharm."},{"key":"42894_CR49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jamda.2020.10.027","volume":"22","author":"JK Sluggett","year":"2021","unstructured":"Sluggett, J. K. et al. Variation in provision of collaborative medication reviews on entry to long-term care facilities. J. Am. Med. Dir. Assoc. 22, 148-155.e1 (2021).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"42894_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40266-016-0362-5","volume":"33","author":"MS Salahudeen","year":"2016","unstructured":"Salahudeen, M. S. & Nishtala, P. S. Examination and estimation of anticholinergic burden: Current trends and implications for future research. Drugs Aging 33, 305\u2013313 (2016).","journal-title":"Drugs Aging"},{"key":"42894_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton, K., Woodman, R. J. & Mangoni, A. A. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. Br. J. Clin. Pharmacol. 80, 209\u2013220 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"42894_CR52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/jcm11030714","volume":"11","author":"MS Salahudeen","year":"2022","unstructured":"Salahudeen, M. S. et al. Effectiveness of interventions to improve the anticholinergic prescribing practice in older adults: A systematic review. J. Clin. Med. 11, 714 (2022).","journal-title":"J. Clin. Med."},{"key":"42894_CR53","first-page":"17","volume":"64","author":"L Bjerre","year":"2018","unstructured":"Bjerre, L. et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia evidence-based clinical practice guideline. Can. Fam. 64, 17 (2018).","journal-title":"Can. Fam."},{"issue":"535","key":"42894_CR54","first-page":"e1","volume":"16","author":"N Jokanovic","year":"2015","unstructured":"Jokanovic, N., Tan, E. C. K., Dooley, M. J., Kirkpatrick, C. M. & Bell, J. S. Prevalence and factors associated with polypharmacy in long-term care facilities: A systematic review. J. Am. Med. Dir. Assoc. 16(535), e1-535.e12 (2015).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"42894_CR55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00228-016-2075-4","volume":"72","author":"S Lalic","year":"2016","unstructured":"Lalic, S. et al. Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: A cross-sectional study. Eur. J. Clin. Pharmacol. 72, 1117\u20131124 (2016).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"42894_CR56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.sapharm.2016.06.003","volume":"13","author":"N Jokanovic","year":"2017","unstructured":"Jokanovic, N. et al. Prioritizing interventions to manage polypharmacy in Australian aged care facilities. Res. Social Adm. Pharm. 13, 564\u2013574 (2017).","journal-title":"Res. Social Adm. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42894-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:16:53Z","timestamp":1700626613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42894"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42894-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2796725\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15962"}}